The significance of QKI deregulation in brain tumors is further highlighted by the observation that 90% of angiocentric gliomas, a type of low-grade pediatric glioma, contain MYB-QKI fusions, which transform cells by concomitantly activating MYB and suppressing QKI (19, 20). This evidence concerns the gene MYB and glioma.